190 related articles for article (PubMed ID: 7415216)
1. Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes.
Inoue T; Niwaguchi T; Murata T
Xenobiotica; 1980 May; 10(5):343-8. PubMed ID: 7415216
[TBL] [Abstract][Full Text] [Related]
2. Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes.
Inoue T; Niwaguchi T; Murata T
Xenobiotica; 1980 Dec; 10(12):913-20. PubMed ID: 7210704
[TBL] [Abstract][Full Text] [Related]
3. Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD).
Niwaguchi T; Inoue T; Nakahara Y
Biochem Pharmacol; 1974 Mar; 23(6):1073-8. PubMed ID: 4151050
[No Abstract] [Full Text] [Related]
4. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of LSD in vitro metabolism by liquid chromatography and capillary electrophoresis coupled with tandem mass spectrometry.
Cai J; Henion J
J Anal Toxicol; 1996; 20(1):27-37. PubMed ID: 8837948
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use.
Luethi D; Hoener MC; Krähenbühl S; Liechti ME; Duthaler U
Biochem Pharmacol; 2019 Jun; 164():129-138. PubMed ID: 30981875
[TBL] [Abstract][Full Text] [Related]
8. Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD).
Niwaguchi T; Inoue T; Sakai T
Biochem Pharmacol; 1974 Nov; 23(21):3063-6. PubMed ID: 4429602
[No Abstract] [Full Text] [Related]
9. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
[TBL] [Abstract][Full Text] [Related]
10. Additional routes in the metabolism of phenacetin.
Fischbach T; Lenk W
Xenobiotica; 1985 Feb; 15(2):149-64. PubMed ID: 4002737
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenobarbital, dexamethasone, and 3-methylcholanthrene administration on the metabolism of 17 beta-estradiol by liver microsomes from female rats.
Suchar LA; Chang RL; Thomas PE; Rosen RT; Lech J; Conney AH
Endocrinology; 1996 Feb; 137(2):663-76. PubMed ID: 8593816
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of lovastatin--III. Effect of cimetidine and famotidine on in vitro metabolism of lovastatin by rat and human liver microsomes.
Vyas KP; Kari PH; Wang RW; Lu AY
Biochem Pharmacol; 1990 Jan; 39(1):67-73. PubMed ID: 2297361
[TBL] [Abstract][Full Text] [Related]
13. Biphenyl hydroxylations and spectrally apparent interactions with liver microsomes from hamsters pre-treated with phenobarbitone and 3-methylcholanthrene.
Burke MD; Bridges JW
Xenobiotica; 1975 Jun; 5(6):357-76. PubMed ID: 238342
[TBL] [Abstract][Full Text] [Related]
14. The metabolism of lysergic acid DI[14C]ethylamide ([14C]LSD) in the isolated perfused rat liver.
Siddik ZH; Barnes RD; Dring LG; Smith RL; Williams RT
Biochem Pharmacol; 1979 Oct; 28(20):3081-91. PubMed ID: 518707
[No Abstract] [Full Text] [Related]
15. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
Metcalfe SA; Colley PJ; Neal GE
Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
[TBL] [Abstract][Full Text] [Related]
16. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK.
Murphy SE; Nunes MG; Hatala MA
Chem Biol Interact; 1997 Mar; 103(3):153-66. PubMed ID: 9134006
[TBL] [Abstract][Full Text] [Related]
17. Regioselectivity of hydroxylation of prostaglandins by liver microsomes supported by NADPH versus H2O2 in methylcholanthrene-treated and control rats: formation of novel prostaglandin metabolites.
Holm KA; Engell RJ; Kupfer D
Arch Biochem Biophys; 1985 Mar; 237(2):477-89. PubMed ID: 3856417
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
Noshiro M; Harada N; Omura T
J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
[No Abstract] [Full Text] [Related]
19. Metabolism of lysergic acid diethylamide (LSD): an update.
Libânio Osório Marta RF
Drug Metab Rev; 2019 Aug; 51(3):378-387. PubMed ID: 31266388
[TBL] [Abstract][Full Text] [Related]
20. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
